Position in PCVX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$201,092,770
+$15,066,216 QoQ
Shares Held
3,459,363
+8.1% QoQ
Ownership
2.32%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 329 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. PCVX ranks #26 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in PCVX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $201,092,770 | 3,459,363 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $186,026,554 | 3,201,283 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $132,251,312 | 2,866,305 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $103,883,120 | 2,884,040 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $97,892,160 | 3,011,140 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $108,335,478 | 2,869,054 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $229,444,411 | 2,802,888 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $308,618,358 | 2,700,782 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $184,378,203 | 2,441,772 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $156,250,586 | 2,287,375 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $123,936,176 | 1,973,506 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $95,593,311 | 1,875,114 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $84,159,587 | 1,685,214 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $49,823,625 | 1,329,339 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $60,006,212 | 1,251,433 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $21,474,864 | 894,786 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,966,163 | 779,695 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $17,435,406 | 721,963 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $15,599,507 | 655,717 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $15,997,484 | 630,567 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $11,682,104 | 518,974 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,312,538 | 420,888 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $7,986,330 | 300,577 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $14,439,353 | 292,413 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $806,876 | 25,526 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||